Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,839
Closed -$292K 1537
2025
Q4
$292K Buy
+5,839
New +$281K ﹤0.01% 1150
2023
Q3
Sell
-17,583
Closed -$542K 1357
2023
Q2
$542K Sell
17,583
-266
-1% -$7.78K ﹤0.01% 807
2023
Q1
$550K Buy
17,849
+959
+6% +$36.5K ﹤0.01% 807
2022
Q4
$634K Buy
+16,890
New +$670K ﹤0.01% 771
2020
Q4
Sell
-2
Closed 2098
2020
Q3
$0 Hold
2
﹤0.01% 2573
2020
Q2
$0 Sell
2
-160
-99% -$3.1K ﹤0.01% 2605
2020
Q1
$6K Hold
162
﹤0.01% 2631
2019
Q4
$6K Buy
162
+160
+8,000% +$5.88K ﹤0.01% 2631
2019
Q3
$0 Hold
2
﹤0.01% 3111
2019
Q2
$0 Sell
2
-292
-99% -$10.2K ﹤0.01% 3161
2019
Q1
$10 Buy
+294
New +$10.8K ﹤0.01% 2368
2018
Q2
Sell
-50
Closed -$2K 2280
2018
Q1
$2K Hold
50
﹤0.01% 2609
2017
Q4
$2K Buy
+50
New +$2.37K ﹤0.01% 2609
2017
Q3
Sell
-27
Closed -$1K 2825
2017
Q2
$1K Hold
27
﹤0.01% 2607
2017
Q1
$1K Hold
27
﹤0.01% 2607
2016
Q4
$1K Hold
27
﹤0.01% 2424
2016
Q3
$0 Hold
27
﹤0.01% 2668
2016
Q2
$0 Hold
27
﹤0.01% 2686
2016
Q1
$0 Hold
27
﹤0.01% 2714
2015
Q4
$0 Hold
27
﹤0.01% 2762
2015
Q3
$0 Hold
27
﹤0.01% 2816
2015
Q2
$0 Buy
+27
New +$781 ﹤0.01% 2762

Other funds holding SNV

Glenmede Trust's SNV Position: Q1 2026 in Review

Glenmede Trust sold out of Synovus (SNV) in Q1 2026, closing a stake of 5,839 shares — an estimated $292K sold.

Glenmede Trust first reported a position in SNV in Q2 2015 and held it in 22 quarters. The position peaked at $634K in Q4 2022. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.

  • Glenmede Trust reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
  • Glenmede Trust sold 5,839 Synovus shares in Q1 2026, an estimated $292K.
  • Glenmede Trust first reported a position in Synovus in Q2 2015 and held it in 22 quarters.
  • Glenmede Trust's Synovus position peaked at $634K in Q4 2022.
  • 1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.